3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
The cancer blood test maker could have a bright future.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
FBR extends tax return filing deadline to October 14
The Federal Board of Revenue (FBR) extended on Wednesday the deadline for filing income tax returns for tax year 2026 from September 30 to October 14.
The 3rd quarter was a water trap quarter
Johan Gouws, head of wealth advisory services at PPS, shares his views on the local and international markets in the third quarter, as well as Gold Fields' offer to Northern Star.
Fed watchdog finds renovation failures, but no grounds for criminal referral
The long-awaited report by the Fed's inspector general said it found no reasonable grounds to believe federal criminal law had been violated.
Crypto industry gave $8 million to Clarity Act lobbyists who didn't close the deal
In the first half of this year, the sector poured millions into lobbying, with most of it tied to pushing the U.S. market structure bill to a goal it never reached.
Capitec growth steady at almost 20% – but credit losses increase
Graham Lee, executive head of Capitec, talks about the group's financial results.